Latest Financials News

Austco Healthcare has renewed its preferred supplier agreement with a major US healthcare provider, continuing supply of its Tacera nurse call systems to 180 hospitals across 30 states. This extension builds on a lucrative five-year partnership worth over A$49 million.

Orthocell has rapidly expanded its US distributor network for Remplir™, surpassing its target ahead of schedule and positioning itself for imminent sales in the $1.6 billion nerve repair market.

Macquarie Group Limited has announced an ordinary dividend of AUD 1.4663 per security for its perpetual capital notes, payable in June 2025 with partial franking.

Macquarie Group Limited has announced a quarterly ordinary dividend of AUD 1.7124 per security on its perpetual capital notes, with a 35% franking rate and a total distribution yield of 6.79% per annum.

Macquarie Group reported a 5% increase in net profit to A$3.7 billion for FY25, driven by strong asset management and banking results despite a dip in commodities. The group also extended its $2 billion share buyback and declared a solid final dividend.

QBE Insurance Group reported a robust 31% increase in net profit for 2024, declaring its highest dividend in years and outlining a confident outlook for 2025 amid ongoing global risks.

QBE Insurance Group reported robust 8% gross written premium growth in 1Q25, driven by strong momentum in North America and International markets, while managing significant catastrophe claims. The insurer reaffirmed its full-year outlook despite ongoing market challenges.

GQG Partners reported a steady increase in funds under management to US$163.6 billion as of April 30, 2025, driven by strong inflows in International and U.S. Equity strategies.

Coronado Global Resources Inc. posted a $96.2 million net loss for Q1 2025, reflecting weak metallurgical coal prices and ongoing liquidity challenges. The company is navigating covenant waivers and pursuing refinancing amid market uncertainty.

AVITA Medical reported a strong first quarter with revenues up 67% to $18.5 million, driven by expanded commercial sales and new product introductions. Despite a narrower net loss, the company faces ongoing challenges from revenue covenants and macroeconomic pressures.

AVITA Medical reported a robust 67% increase in first quarter 2025 revenue, driven by new product launches and a strategic commercial overhaul, while reaffirming its full-year growth and profitability targets.

Genmin Limited secures a A$2 million unsecured loan from its non-executive Chair to support working capital as it advances the Baniaka iron ore project in Gabon.